M&A TRANSACTION · 2024
Axonics, Inc. acquired by Boston Scientific Corporation
$3.40B· 68.0x EBITDA· 9.30x revenue
Target
Axonics, Inc.
United States and Canada
Axonics, Inc. develops therapies for urinary and bowel dysfunction. The company provides therapies and solutions for these conditions, offering the Axonics System for healthcare professionals and patients. It delivers coding and billing resources and support, along with information and resources through its website. Clients can sign up for updates and receive information about products and services. The company was founded in 2012 and is based in Irvine, California.
Acquirer
Boston Scientific Corporation
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$366.0M
EBITDA
$50.0M
Deal Value
$3.40B
EV/EBITDA
68.0x
Context
This $3.40B acquisition of Axonics, Inc. by Boston Scientific Corporation sits in the medical devices sub-vertical. The 68.0x EBITDA multiple paid in 2024 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub. Boston Scientific Corporation is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.
Source
Data sourced from SEC Fairness Opinion — primary source. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical devices
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Axonics, Inc. acquisition.